Unicharm (8113) Q2 2025 Earnings Report

8 Followers

Previous Report: Q1 2025

Next Report: Q3 2025

JP:8113 Q2 2025 EPS Results

Actual EPS¥9.66

Consensus EPS¥16.83

Beat/MissMissed by -¥7.17

One Year Ago EPS¥12.35

JP:8113 Q2 2025 Revenue Results

Actual Revenue¥236.65B

Expected Revenue¥258.68B

Beat/MissMissed by -¥22.03B

YoY Revenue Growth-5.89%

Earnings Announcement Details

QuarterQ2 2025

Date08/05/2025

TimeBefore Open

Conference CallTuesday, August 5, 2025

JP:8113 Upcoming Earnings

Unicharm's next earnings date is estimated for November 6, 2026, based on past reporting schedules.

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

Q2 2025 Earnings Call Summary

Q2 2025

Earnings Call Date:Aug 05, 2025|

% Change Since:

Earnings Call Sentiment|Neutral

The earnings call highlighted strong performance in Japan and North America, along with strategic shareholder returns. However, significant challenges in Asia, particularly China, and a downward revision of forecasts indicate a cautious outlook.

Company Guidance

In the second quarter of the fiscal year ending December 31, 2025, Unicharm Corporation reported consolidated sales of JPY464.2 billion, a decline of 4.8%, and a core operating income of JPY57 billion, down 22% compared to the previous year. The decline was attributed to the reaction to record-high profits from the same period last year and reputational incidents affecting feminine care sales in China. Strategic marketing investments in Asia and rising logistics and DX-related costs in Japan also pressured earnings. Interim income attributable to owners increased due to JPY5.3 billion in insurance income from India and the utilization of tax loss carryforwards. In Japan, net sales increased by 4.1% and core operating income by 2.9%, driven by the penetration of the value shift in wellness care and pet care. In contrast, Asia saw a significant decline in net sales by 14.5% and core operating income by 69.4%, primarily due to challenges in China, Indonesia, and Thailand. For the rest of the world, net sales increased by 2.3%, and core operating income rose by 12.7%, with a strong performance in North America's pet care business and the Middle East. The company revised its earnings forecast downward, citing slower-than-expected recovery in Asia, ongoing challenges in China, and demographic shifts affecting the baby care market. Unicharm aims for a total return ratio of 50% or more for shareholders, planning to increase dividends and acquire additional treasury stock.

Japan Business Performance

The Japan business achieved a 4.1% increase in net sales and a 2.9% increase in core operating income, marking the highest results ever recorded. This was driven by successful new products and an improved sales mix in wellness and pet care.

Insurance Income in India

Interim income attributable to owners of the parent company increased mainly due to the receipt of JPY5.3 billion in insurance income in India.

Pet Care Growth in North America

Net sales increased 14.6% and income up 25.3% in North America's pet care business, driven by new dog treats and strategic value shifting.

Middle East and Egypt Performance

Net sales increased 2.3%, core operating income rose 12.7%, and core operating margin increased to 14.6% due to strong performance in the Middle East and Egypt.

Dividend Increase and Shareholder Return

The annual dividend was increased by JPY3.3 per share to JPY18 per share, marking the 24th consecutive fiscal year of dividend increase. Additionally, an additional JPY10 billion of treasury stock will be repurchased.

JP:8113 Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 06, 2026	2026 (Q3)	8.91 / -	10.84	―
Aug 05, 2026	2026 (Q2)	11.40 / 12.35	9.66	27.85% (+2.69)
May 08, 2026	2026 (Q1)	11.31 / 11.40	14.18	-19.61% (-2.78)
Feb 12, 2026	2025 (Q4)	13.17 / 2.62	12.667	-79.32% (-10.05)
Nov 07, 2025	2025 (Q3)	9.54 / 10.84	11.32	-4.24% (-0.48)
Aug 05, 2025	2025 (Q2)	16.83 / 9.66	12.353	-21.80% (-2.69)
May 09, 2025	2025 (Q1)	11.78 / 14.18	10.07	40.81% (+4.11)
Feb 13, 2025	2024 (Q4)	-51.43 / 12.67	14.143	-10.44% (-1.48)
Nov 08, 2024	2024 (Q3)	13.70 / 11.32	14.84	-23.72% (-3.52)
Aug 06, 2024	2024 (Q2)	12.56 / 12.35	10.21	20.99% (+2.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed